AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

ESSA Pharma Inc. Director's Dealing 2021

Aug 17, 2021

35249_dirs_2021-08-17_5f3630ad-445f-4c4f-98f0-8061993db75f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2021-08-16

Reporting Person: BIOTECH GROWTH N V (10% Owner)
Reporting Person: BB BIOTECH AG (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	4765814	Direct